1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Janus kinase mutations
    Journal Article

    Levine, R. L.
    Seminars in Oncology (2009)

    Fulltext@MSK | Save
  • Cord blood (Cb) extends transplant access to racial and ethnic minorities: A prospective study of 309 unrelated searches in patients with high-risk hematologic malignancies
    Meeting Abstract

    Lee, S. S.; Scaradavou, A.; Hawke, R. M.; Webb, K. A.; Wells, D. S.; Abboud, M.; Papadopoulos, E. B.; Kernan, N. A.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Expression of cytotoxic T cells in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Koreishi, A. F.; Persky, D. O.; Cui, H.; Moskowitz, A.; Moskowitz, C.; Teruya-Feldstein, J.
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • A germline JAK2 SNP is associated with predisposition to the development of JAK2 V617f-positive myeloproliferative neoplasms
    Meeting Abstract

    Kilpivaara, O.; Mukherjee, S.; Schram, A.; Wadleigh, M.; Mullally, A.; Ebert, R.; Bass, A.; Marubayashi, S.; Heguy, A.; Garcia-Manero, G.; more...
    Haematologica (2009)

    Fulltext@MSK | Save
  • Cutaneous and central nervous system involvement in multiple myeloma
    Meeting Abstract

    Karam, S.; Matushansky, I.; Hassoun, H.
    Journal of General Internal Medicine (2009)

    Fulltext@MSK | Save
  • Distress in older patients with cancer
    Journal Article

    Hurria, A.; Li, D. N.; Hansen, K.; Patil, S.; Gupta, R.; Nelson, C.; Lichtman, S. M.; Tew, W. P.; Hamlin, P.; Zuckerman, E.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Absolute lymphocyte count at day 30 predicts survival in recipients of a T cell depleted allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Goldberg, J. D.; Lai, K. C.; Jakubowski, A. A.; Barker, J. N.; Boulad, F.; Castro-Malaspina, H. R.; Hsu, K. C.; Kernan, N.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • The impact of full dose total body irradiation(TBI)-containing conditioning on chronic kidney disease and thrombotic microangiopathic anemia in allogeneic hematopoietic stem cell transplantation(HSCT)
    Meeting Abstract

    Glezerman, I.; Jhaveri, K.; Papadopouolos, E. B.; Flombaum, C.; Jakubowski, A. A.
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Follicular lymphoma in the United States: First report of the National LymphoCare Study
    Journal Article

    Friedberg, J. W.; Taylor, M. D.; Cerhan, J. R.; Flowers, C. R.; Dillon, H.; Farber, C. M.; Rogers, E. S.; Hainsworth, J. D.; Wong, E. K.; Vose, J. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma
    Journal Article

    Freedman, A.; Neelapu, S. S.; Nichols, C.; Robertson, M. J.; Djulbegovic, B.; Winter, J. N.; Bender, J. F.; Gold, D. P.; Ghalie, R. G.; Stewart, M. E.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save